• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

C
Caballero S.	-	CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
	-	HEPARIN AFFINITY CHROMATOGRAPHY AND ADDITIONAL PURIFICATION STEPS EFFECTIVELY ELIMINATE AN EXPERIMENTAL TSE-MODEL AGENT SPIKED INTO FACTOR VIII/VWF PRODUCTION PROCESS
	-	NANOFILTRATION APPLIED TO FACTOR IX PURIFICATION PROCESS EFFECTIVELY ELIMINATES AN EXPERIMENTAL TSE-MODEL AGENT
Cabral E.	-	THROMBOCYTOPENIA: ANALYSIS OF 317 PATIENTS
Cabrera J.L.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Cabrera N.	-	IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
Cacciavillani S.	-	PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION?
Caciolli S.	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
Cadiou G.	-	RISK FACTOR FOR ORAL ANTICOAGULANT TREATMENT OVERDOSE: A CASE CONTROL STUDY IN AN EMERGENCY UNIT
Caferri H.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Caglar T.	-	THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Cagney G.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
Cahill P.A.	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
Cahill A.	-	INFERIOR VENA CAVA FILTERS IN PEDIATRIC PATIENTS
Cahill P.A.	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
Cai W.	-	HAPLOTYPES IN THE PROMOTER REGION OF BETA-FIBRINOGEN GENE AND THEIR RELATIONSHIP TO ISCHEMIC STROKE IN HAINAN HAN POPULATION IN CHINA
Cai L.	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Caimi T.M.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Caire P.	-	MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
Cairo F.	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Cakir B.F.	-	RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Calabrese F.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Calabrò M.	-	IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA
Calaminus S.D.	-	COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES
Calatzis A.	-	PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY
	-	INFLUENCE OF FV LEIDEN ON THE KINETICS OF THROMBIN FORMATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST (TDT)
	-	EFFECT OF VARIATIONS OF SINGLE FACTOR ACTIVITY ON THROMBIN GENERATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST
	-	MONITORING OF ANTIPLATELET THERAPY BEFORE AND AFTER SURGICAL PROCEDURES IN PATIENTS WITH CORONARY STENTS
	-	THE EFFECT OF ADP RECEPTOR ANTAGONISTS AND ASPIRIN ON WHOLE BLOOD PLATELET AGGREGATION MEASURED BY MULTIPLE ELECTRODE AGGREGOMETRY
	-	EFFECTIVENESS OF CHRONIC ANTIPLATELET TREATMENT BY ASPIRIN OR CLOPIDOGREL AS DETERMINED BY MULTIPLE ELECTRODE AGGREGOMETRY
Calcaterra J.	-	EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
Caldarone C.A.	-	EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
Calderazzo J.	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
Calderazzo J.C.	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
Caldini A.	-	DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
Calhoun R.	-	SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
Caliandro R.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Califano S.	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
Caliskan U.	-	A TURKISH PATIENT WITH COMBINED DEFICIENCY OF VITAMIN K-DEPENDENT CLOTTING FACTORS
Calkin A.C.	-	HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
Callebert J.	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
Callejas M.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Calleri A.	-	CIRCULATING ENDOTHELIAL CELLS (CECS) AND PROGENITORS (CEPS) IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
Calò L.	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
Calvert M.	-	MONITORING UNFRACTIONATED HEPARIN IN A PATIENT WITH RENAL AND HEPATIC INSUFFICIENCY YIELDS DISCORDANT RESULTS COMPARING ANTI-XA ASSAY AND PARTIAL THROMBOPLASTIN TIME. A CASE REPORT
Calvez T.	-	PLASMA-DERIVED VERSUS RECOMBINANT PRODUCTS FOR HAEMOPHILIA TREATMENT ?
	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Calzavarini S.	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Cámara C.	-	LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Camarasa P.	-	ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES
Cambus J.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
Camera M.	-	E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
	-	BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
	-	EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
	-	ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
Cameron P.	-	THE HAEMOSTASIS REGISTRY AUSTRALIAN AND NEW ZEALAND EXPERIENCE WITH RFVIIA
Cameron C.L.	-	INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Camilleri R.S.	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
Camire R.M.	-	MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
	-	THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
	-	NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS
	-	EVOLUTIONARY CONSERVED B-DOMAIN SEQUENCES CONTRIBUTE TO MAINTAINING FACTOR V AS A PROCOFACTOR
Camoin L.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
	-	STANDARDIZATION OF MICROPARTICLE COUNTING USING FLOW CYTOMETRY: NEW OPTIONS AND TOOLS FOR THE CONTROL OF CRITICAL INSTRUMENT SETTINGS
	-	COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE
Camoin-Jau L.	-	VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
	-	SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS
Campagnolo E.	-	ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
Campanini M.	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Campbell S.A.	-	CLINICAL APPLICATIONS OF A DIRECT GENOMIC PLATFORM FOR SNP DETECTION IN HUMAN DNA SAMPLES USING GOLD NANOPARTICLE PROBE TECHNOLOGY AND ENHANCED SIGNAL AMPLIFICATION
Campo G.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Camporese G.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
	-	BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
	-	INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
	-	GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
Campos L.	-	TFPI LEVELS AND HAEMORRHAGIC EVENTS IN HAEMOPHILIC PATIENTS
Campos M.	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
Campos M.M.	-	FACTOR V LEIDEN AS A THROMBOPHILIA'S MARKER IN LIVER TRANSPLANTATION - AN EVALUATION
Campos L.	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
Campus F.	-	EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
Canak V.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Canavesi M.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Canciani M.T.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO
	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
Cane M.C.	-	A CRYO-ELECTRON MICROSCOPY STUDY OF RECOMBINANT FVIII BINDING TO PS LIPOSOMES
Canella A.	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
Canivel D.	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
	-	COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
Cannegieter S.C.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Cannegieter S.	-	BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
Cannegieter S.C.	-	THE ABSOLUTE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL: EFFECT OF RISK FACTORS AND BEHAVIOUR DURING FLIGHTS
	-	HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
	-	AIR TRAVEL AND VENOUS THROMBOSIS: A SYSTEMATIC REVIEW
	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
	-	THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER
	-	THE EFFECT OF FLIGHT-RELATED BEHAVIOUR ON THE RISK OF VENOUS THROMBOSIS AFTER AIR TRAVEL
	-	ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
	-	PREDICTION OF BLEEDING AND THROMBOTIC EVENTS IN PATIENTS WITH MECHANICAL HEART VALVE PROSTHESES TREATED WITH ORAL ANTICOAGULANTS
	-	LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS
Cano H.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Canpolat C.	-	RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Cantillon C.	-	SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Cantini M.	-	FAILURE OF IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA B PATIENTS WITH C, T 6460 NONSENSE MUTATION
Cantinieaux B.	-	RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY
Canu P.	-	BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
Cao Z.	-	THE SYNERGISTIC EFFECTS OF SYNTHETIC PHOSPHOLIPIDS AND RECOMBINANT TISSUE FACTOR IN THE OPTIMIZATION OF A PROTEIN S ASSAY SENSITIVITY
	-	THROMBOPATH KIT CORRELATES BETTER WITH FREE PROTEIN S TO PROTHROMBIN RATIO AND FUNCTIONAL PS THAN WITH FREE PS
	-	SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN
Capaci K.	-	RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Capalbo A.	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
Capogrossi M.	-	THROMBIN-MEDIATED IMPAIRMENT OF FGF-2 ACTIVITY
Capone C.	-	OPTIMIZING CARE VIA INTERNET-BASED HEMOPHILIA THERAPY MANAGEMENT PLATFORM
Caporale R.	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
Cappelli R.	-	HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) AND THE RISK OF FIRST EVER ISCHEMIC STROKE IN HEALTHY PEOPLE
Cappucci F.	-	A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS
	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
Caprini J.A.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
	-	THE ORAL DIRECT THROMBIN INHIBITOR, DABIGATRAN ETEXILATE, IS EFFECTIVE AND SAFE FOR PREVENTION OF MAJOR VENOUS THROMBOEMBOLISM FOLLOWING MAJOR ORTHOPEDIC SURGERY
Capron C.	-	PLATELET CHEMOTAXIS INDUCED BY THE SDF-1/CXCR4 CHEMOKINE RECEPTOR SYSTEM
Caramella M.	-	FLUID LOSS, COAGULATION ACTIVATION AND AIR TRAVEL
Carazzolle M.F.	-	ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS
Carbo C.	-	ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Card D.J.	-	URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Cardigan R.A.	-	QUALITY MONITORING OF FRESH-FROZEN PLASMA (FFP) AND THE EFFECT OF WHOLE BLOOD STORAGE AT 4C OVERNIGHT
	-	EFFECT OF METHYLENE BLUE (MB) TREATMENT OF FRESH FROZEN PLASMA (FFP) ON CALIBRATED AUTOMATED THROMBOGRAPHY (CAT) AND ROTATIONAL THROMBOELASTOMETRY (ROTEM)
Cardona F.	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Carling D.	-	THROMBIN STIMULATES AMP-ACTIVATED PROTEIN KINASE IN ENDOTHELIAL CELLS VIA A CAMKK-BETA-DEPENDENT PATHWAY
Carlisle C.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Carlo A.	-	THE EFFECT OF HIRUDIN ON THROMBIN GENERATION, APTT AND ECARIN CLOTTING TIME (ECT)
	-	NORMALISATION OF TGT RESULTS: IT MAY NOT BE AS EASY AS YOU THINK
	-	ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM
Carloni M.	-	HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
Carluccio M.A.	-	HYDROXYTYROSOL, THE MAJOR OLIVE OIL PHENOLIC ANTIOXIDANT, REGULATES EXPRESSION AND ACTIVITY OF MATRIX METALLOPROTEINASE(MMP)-9 IN HUMAN MONOCYTOID CELLS - POSSIBLE CONTRIBUTION TO PLAQUE STABILITY
	-	HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
Carluccio M.	-	HOMOCYSTEINE INDUCES VCAM-1 GENE EXPRESSION THROUGH NF-KB AND NAD(P)H OXIDASE ACTIVATION: PROTECTIVE ROLE OF MEDITERRANEAN DIET POLYPHENOLIC ANTIOXIDANTS
	-	THE OMEGA-3 FATTY ACID DOCOSAHEXAENOATE (DHA) REDUCES CYCLOOXYGENASE(COX)-2 INDUCTION BY INHIBITING NADP(H) OXIDASE AND PKC: POSSIBLE INVOLVEMENT OF 15-LIPOXIGENASE(LO)-1
	-	THE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR(PPAR)GAMMA AGONIST ROSIGLITAZONE (RSG) INHIBITS CYCLOOXYGENASE(COX)-2 EXPRESSION BY SUPPRESSING PKCAPLHA AND CREB ACTIVATION
Carman T.L.	-	RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN A TERTIARY CARE POPULATION
Carmassi F.	-	WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE
Carnarius H.	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Carneiro J.D.A.	-	NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER
Carneiro J.	-	PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF ORAL ANTICOAGULATION THERAPY IN URGENT SITUATIONS. EXPERIENCE OF A SINGLE CENTER
Carneiro J.D.A.	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Carneiro-Proietti A.B.F.	-	MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY
	-	DURATION OF SYMPTOMS AND D-DIMER TESTING FOR VENOUS THROMBOEMBOLISM RULING-OUT
Carnevale R.	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Carnevale L.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Carnevale R.	-	LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION
	-	LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
Caron C.	-	IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
Carpenedo M.	-	D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Carr M.E.	-	EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
Carraro P.	-	TIME COURSE OF COAGULATION FACTORS IN OVERT DISSEMINATED INTRAVASCULAR COAGULATION: A CASE STUDY
Carratù M.R.	-	IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
Carreras C.	-	EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
Carreras E.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Carreras M.	-	THE EFFECTS OF DOCOSAHEXAENOIC ACID IN PLATELETS (AN EX VIVO STUDY) AND IN MEGAKARYOCYTIC CELLS (AN IN VITRO STUDY)
Carreras E.	-	ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
Carrier M.	-	ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS
	-	SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) EVALUATION (SOME TRIAL): A PROSPECTIVE PILOT COHORT STUDY USING COMPREHENSIVE ABDOMEN/PELVIS COMPUTED TOMOGRAPHY (CCT)
Carrijo Carvalho C.L.C.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Carrillo M.	-	ZEBRAFISH: FROM HEMATOLOGY TO HYDROLOGY
Carrivale M.	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
Carruthers D.	-	RAISED CIRCULATING ENDOTHELIAL CELLS IN RHEUMATOID AND EARLY ARTHRITIS
	-	ANGIOGENESIS IN RHEUMATOID ARTHRITIS: IS IT RELATED TO ENDOTHELIAL PERTURBATION AND/OR INFLAMMATION?
Carson N.	-	FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
Carson P.	-	CLINICAL OUTCOMES OF POINT-OF-CARE INR MONITORING FOR ANTICOAGULATION IN PRIMARY CARE PRACTICE
Carter A.M.	-	HERITABILITY OF MEASURES OF CLOT TURBIDITY AND CLOT LYSIS IN THE LEEDS FAMILY STUDY
	-	ALANINE AMINOTRANSFERASE, ATHEROTHROMBOTIC RISK FACTORS AND METABOLIC SYNDROME IN SOUTH ASIANS
Carter C.J.	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
Carter A.M.	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
Carter A.	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Carter L.	-	PHARMACOLOGICAL TARGETING OF PLATELETS BY ORALLY ACTIVE PI3-KINASE B INHIBITOR PROTECTS AGAINST ARTERIAL THROMBOSIS
	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Cartwright I.	-	FACTOR VIII ASSAY DISCREPANCY IN TYPE 2N VWD IS REAGENT DEPENDANT
Caruso P.	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
	-	VITAMIN K-INDUCED VARIATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY
Caruso V.	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
Carvajal Z.	-	EFFECT OF HOMOCYSTEINE ON CLOT STRUCTURE AND FIBRINOLYSIS
Carvalho M.G.	-	PLASMA THROMBOMODULIN IN PRE-ECLAMPSIA
	-	SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
	-	HEMOSTATIC PROFILE IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD): ASSOCIATION TO ANKLE-BRACHIAL INDEX (ABI)
	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
	-	FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE
	-	LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	TISSUE FACTOR AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN CORONARY ARTERY DISEASE: CORRELATION WITH THE SEVERITY OF ATHEROMATOSIS
	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
	-	ASSOCIATION BETWEEN PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND SMOKING IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	ASSOCIATION OF OXIDIZED LDL AND LP(A) LIPOPROTEIN WITH EXTENT OF CORONARY ARTERY DISEASE BY ANGIOGRAPHY
	-	LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
	-	RISK FACTORS ASSOCIATED TO THE DEVELOPMENT OF PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
	-	CORONARY ARTERY DISEASE (CAD): LACK OF ASSOCIATION BETWEEN APOB/APOA-I RATIO AND ATHEROMATOSIS EXTENT
	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	APOB/APOA-I RATIO IN PATIENTS WITH ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL DISEASE
	-	HOMOCYSTEINE PLASMA LEVELS AND MTHFR C677T MUTATION IN PATIENTS WITH CORONARY ARTERIAL DISEASE, ISCHEMIC STROKE AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE
	-	SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
	-	APO B ECORI AND INSERTION/DELETION POLYMORPHISMS IN BRAZILIAN YOUNG PATIENTS WITH ISQUEMIC STROKE
	-	TFPI PLASMA LEVELS IN WOMEN WITH PRE-ECLAMPSIA
Carvalho M.	-	PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF ORAL ANTICOAGULATION THERAPY IN URGENT SITUATIONS. EXPERIENCE OF A SINGLE CENTER
Carvalho M.G.	-	PLASMA LEVELS OF HOMOCYSTEINE (HCY) AND OTHER PARAMETERS INTERRELATED IN PATIENTS WITH PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
Carvas J.M.	-	HYPERACTIVE C-JUN N-TERMINAL KINASE ENHANCES VASCULAR TISSUE FACTOR EXPRESSION IN AGING
Casais P.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
	-	POISONING WITH SUPERWARFARIN
	-	THROMBOPHILIA TESTING IN A DEVELOPING COUNTRY REFERRAL CENTER: A 3-YEAR OBSERVATIONAL STUDY
	-	MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
Casaña P.	-	IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
Casanegra A.I.	-	CLINICAL AUDIT OF THROMBOEMBOLISM PROPHYLAXIS 3 YEARS AFTER THE 6TH ACCP REPORT IN A TERTIARY CARE HOSPITAL FROM CRDOBA, ARGENTINA
Casaní L.	-	THROMBOXANE A2/PROSTAGLANDIN H2 RECEPTOR BLOCKER (S18886) SHOWS ANTITHROMBOTIC EFFICACY SIMILAR TO ASPIRIN PLUS CLOPIDOGREL IN STENT-INDUCED THROMBOSIS
Casani L.	-	BENEFICIAL EFFECTS OF DAILY OLIVE OIL CONSUMPTION IN THROMBOSIS. STUDIES IN NORMOLIPEMIC PIGS
Casazza F.	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Casella L.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Caser L.	-	TREATMENT OF SURGICAL PATIENTS WITH FRESH FROZEN PLASMA AT THE CLINICAL HOSPITAL CENTER RIJEKA
Casetta B.	-	A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY
Casey K.	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
Casey C.R.	-	LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY
Casini A.	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
Caso V.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Casonato A.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
Casonato S.	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
Casonato A.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
Cassee F.R.	-	EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
	-	LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
Cassinat B.	-	HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
Castagnaro M.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Castaldo G.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
Castaman G.	-	SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	SEVERE SPONTANEOUS ARTERIAL THROMBOTIC MANIFESTATIONS IN PATIENTS WITH INHERITED HYPO- AND AFIBRINOGENEMIA
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	A BAYESIAN APPROACH TO THE DIAGNOSIS OF TYPE 1 VON WILLEBRAND DISEASE
	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
	-	A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE
	-	HOW TO ESTIMATE BLEEDING RISK IN MILD BLEEDING DISORDERS
	-	REPORT OF THE SC-VWF WORKING PARTY ON VWF ASSAYS IN VWD DIAGNOSES
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Castaño M.	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
Castañón M.	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
Castedo G.	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
Castellani S.	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Castellano I.	-	LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Castelli M.	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
Castellino F.J.	-	THE PROTECTIVE ROLE OF PROTEIN C IN ENDOTOXIN-INDUCED SHOCK
Castello R.	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
	-	FIBRINOLYTIC INHIBITORS LEVELS AND POLYMORPHISMS IN BEHCET DISEASE. THEIR RELATIONSHIP WITH VENOUS THROMBOSIS
	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
Castellone D.D.	-	COMPARISON OF PIFA RAPID ASSAY WITH ELISA TO DETECT HEPARIN/PLATELET FACTOR 4 (HPF4) ANTIBODIES
	-	A CHROMOGENIC METHOD FOR QUANTITATION OF DIRECT THROMBIN INHIBITORS: A CASE STUDY
	-	EVALUATION OF A RAPID PARTICLE GEL IMMUNO ASSAY (PAGIA) FOR DETECTION OF HEPARIN/PF4 ANTIBODIES (HPA)
Castillo J.	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
Castillo M.	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Castoldi E.	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION
	-	ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET)
Castro V.	-	HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER
Casuccio A.	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
Catala M.	-	NEW APPROACH FOR DETECTION OF HEPARIN DEPENDENT ANTIBODIES AND RISK ASSESSMENT FOR HEPARIN INDUCED THROMBOCYTOPENIA
	-	INCIDENCE OF THE VARIOUS HEPARIN DEPENDENT ANTIBODY ISOTYPES IN A GROUP OF PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA
Catani M.	-	MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
Catania M.	-	CLINICAL APPLICATIONS OF A DIRECT GENOMIC PLATFORM FOR SNP DETECTION IN HUMAN DNA SAMPLES USING GOLD NANOPARTICLE PROBE TECHNOLOGY AND ENHANCED SIGNAL AMPLIFICATION
Catozzi L.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Cattaneo M.	-	MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
	-	ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
	-	HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
	-	RESISTANCE TO ANTI-PLATELET DRUGS: MOLECULAR MECHANISMS AND LABORATORY DETECTION
Cattini M.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Cattozzo G.	-	BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
Cauchie P.	-	USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
Cauchie C.	-	USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
Causse M.	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
Cavalheiro-Filho C.	-	DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Cavallari N.	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
Cavasin N.	-	INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
Cavazzana A.	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
Cavazzana-Calvo M.	-	BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
Cavdar Z.	-	ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS
Cavenagh J.	-	SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
Cavoni A.	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
Cawthern K.	-	MULTIFACTORIAL ANALYSIS USING FOUR PHOSPHOLIPIDS TO THOROUGHLY INVESTIGATE CONTROL OF THROMBOPLASTIN PROPERTIES AND SENSITIVITIES
	-	THE IMPACT OF PHOSPHOLIPID COMPOSITION ON THE INTERFERENCE CAUSED BY THE ANTIBIOTIC DAPTOMYCIN IN THROMBOPLASTIN REAGENTS
Cazenave J.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
	-	MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
Cazenave J.P.	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
	-	IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
	-	VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES
Cecchetti L.	-	RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES
	-	PLATELET-DERIVED NITRIC OXIDE CONTRIBUTE TO THE REGULATION OF BLOOD PRESSURE IN MICE
Cecchi E.	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Ceccon M.E.J.	-	NEONATAL THROMBOSIS: A SERIES OF 18 CASES FROM A BRAZILIAN PEDIATRIC CENTER
Cécile D.V.	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
Cedeño M.	-	USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Celentano A.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Celkan T.	-	LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Cella G.	-	EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
	-	ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
	-	DEFIBROTIDE AND ITS MOLECULAR FRACTIONS DO NOT CROSS-REACT WITH HIT ANTIBODIES. IMPLICATIONS IN THE MANAGEMENT OF HIT
	-	SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
Cellai A.	-	QUALITY OF OAT AND VTE RECURRENCE
	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
Cen J.	-	QUANTITATIVE ANALYSIS OF GENE EXPRESSION FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS APPLICATION
Centenaro C.	-	EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
Centritto F.	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
Centurioni R.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Ceppi S.	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
Cera L.	-	RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS
Cerbone A.M.	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Ceresa E.	-	BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT
Ceresetto J.M.	-	PROLONGED DVT PROPHYLAXIS IS BETTER THAN STANDARD PROPHYLAXIS IN MAJOR ABDOMINAL SURGERY: A META-ANALYSIS
	-	LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
Ceresetto J.	-	EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
Ceriello A.	-	PROTHROMBOTIC FACTORS AND OXIDATIVE STRESS MARKERS IN A TYPE 2 DIABETES POPULATION
Cerini C.	-	THE UREMIC SOLUTE INDOXYL SULFATE INDUCES OXIDATIVE STRESS IN ENDOTHELIAL CELLS
Cerletti C.	-	DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD
	-	RESPONSE VARIABILITY TO ASPIRIN AS ASSESSED BY A PLATELET FUNCTION-ANALYZING DEVICE IN 5,007 SUBJECTS: A SYSTEMATIC REVIEW OF 40 STUDIES
	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
	-	PLATELET BUT NOT LEUKOCYTE ACTIVATION IS A PREREQUISITE FOR PLATELET-LEUKOCYTE INTERACTION IN HUMAN WHOLE BLOOD
	-	DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN
	-	GALLIC ACID BLUNTS PLATELET INHIBITION BY ASPIRIN AND OTHER POLYPHENOLS: IMPLICATIONS FOR THE ANTITHROMBOTIC PROPERTIES OF ASPIRIN AND DIETARY POLYPHENOLS
	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
Cermelj M.	-	TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
Cerrato G.S.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
	-	CORRELATION BETWEEN DIFFERENT FIBRINOLYTIC TESTS IN PATIENTS WITH OBSTETRIC COMPLICATIONS
Cervera A.	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
Cervera-Ceballos E.	-	A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS
Cervi D.	-	PLATELET-FACILITATED DELIVERY OF ANGIOGENESIS REGLULATORS IS CONTROLLED BY TISSUE PROTEASES
Cesari F.	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
Cetkovský P.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Cevreska L.	-	INTENSIVE PLASMA EXCHANGE WAKES UP PATIENT WITH TTP IN COMA
Châabane C.	-	CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Chabrak S.	-	ASSOCIATION OF HYPERHOMOCYSTEINEMIA WITH RESTENOSIS
Chafa C.O.	-	SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
Chafa O.	-	SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
Chaganti S.K.	-	EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY
	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
Chahwala S.B.	-	FLOVAGATRAN (TGN 255), BIVALIRUDIN AND MELAGATRAN - DIFFERENTIAL PHARMACOLOGICAL EFFECTS ON THROMBIN GENERATION
Chaireti R.I.	-	DOES THROMBIN GENERATION OR D-DIMER VALUES AT TIME OF AN ACUTE EVENT OF VENOUS THROMBO-EMBOLISM PREDICT RECURRENCES?
Chakroun T.	-	INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA
Chalendard J.	-	SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
Chaleteix C.	-	SECONDARY PROPHYLAXIS WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A SEVERE HAEMOPHILIA A PATIENT WITH ANTI-FACTOR VIII INHIBITORS
Chambefort V.	-	DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
Chamberlain D.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Chambers C.	-	TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
Chambost H.	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Chammas M.	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
Chamone D.F.	-	MUNCHAUSEN SYNDROME X COAGULOPATHIES
	-	DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS
Chamone D.A.F.	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Chamone D.F.	-	ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT
Chamorro A.	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
Chamouard V.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
Chan A.	-	OUTCOMES OF THROMBOLYSIS FOR REPEATED COURSES OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR INTRAVASCULAR THROMBOSIS IN CHILDREN
Chan M.	-	THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
Chan D.	-	PAI-1 IN PLATELETS IS DEPENDENT ON THE 4G/5G POLYMORPHISM
Chan A.	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
Chan A.K.C.	-	CHEMOTHERAPY AFFECTS ACTIVATED PROTEIN C GENERATION TO A GREATER DEGREE IN NEWBORN THAN IN ADULT PLASMA
	-	DO WE NEED DIFFERENT STANDARD CURVES FOR MEASURING DIFFERENT LOW MOLECULAR WEIGHT HEPARINS?
	-	EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Chan K.	-	REFERENCE VALUES FOR THROMBOELASTOGRAPHY IN HEALTHY CHILDREN
Chan A.K.C.	-	INFLUENCE OF COVALENT ANTITHROMBIN-HEPARIN COMPLEX ON FIBROBLAST GROWTH FACTOR EXPRESSION AND LUNG ANGIOGENESIS
Chan A.	-	EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
Chan A.K.	-	EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
Chan A.	-	THE EFFICACY AND SAFETY OF ANTITHROMBIN CONCENTRATE IN CHILDREN RECEIVING HEPARIN INFUSIONS
Chan D.	-	PLATELETS INDUCE PAI-1 GENE EXPRESSION IN MONOCYTES THROUGH TGF-BETA
	-	ACTIVATED PLATELETS INDUCE TISSUE FACTOR PATHWAY INHIBITOR IN PERIPHERAL BLOOD MONOCYTES
Chan K.N.K.	-	THE CENTRAL ROLE OF THROMBIN IN HAEMOSTASIS
Chan A.K.C.	-	1800NOCLOTS WHAT HAVE WE LEARNED FROM THIS FREE CONSULTATIVE SERVICE
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX NEUTRALIZES PROCOAGULANT ACTIVITY INDUCED BY VENTILATION IN NEWBORNS
	-	EFFECT OF AGE ON THE RELATIONSHIP BETWEEN RATE OF HEPARIN-CATALYZED INHIBITION OF COAGULATION FACTORS BY ANTITHROMBIN AND IN VIVO PLASMA CONCENTRATION
Chan A.K.	-	DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS
	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Chan A.K.C.	-	NEONATAL RENAL VEIN THROMBOSIS - 15 YEARS OF LITERATURE
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX REDUCES BRAIN EMBOLI DURING HYPOTHERMIC CARDIOPULMONARY BYPASS IN PIGS
	-	DETERMINATION OF THROMBIN-ALPHA2MACROGLOBULIN COMPLEXES BY A NEW IMMUNO-ACTIVITY ASSAY
	-	MANAGEMENT OF VENOUS AND ARTERIAL THROMBOSIS IN CHILDREN
Chan D.	-	CIRCADIAN VARIATION IN THE PLATELET RESPONSE AND THE EFFECT OF MELATONIN
Chan A.K.	-	CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN CHILDHOOD- EXPERIENCE FROM A SINGLE CENTRE
Chan A.	-	COMPARISON OF SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR VENOUS THROMBI AND ARTERIAL THROMBI IN CHILDREN
	-	THE EFFICACY AND SAFETY OF FRESH FROZEN PLASMA (FFP) AND SYSTEMIC TISSUE PLASMINOGEN ACTIVATOR FOR TREATMENT OF INTRAVASCULAR THROMBOSIS IN INFANTS
Chan A.K.C.	-	DIFFERENTIAL DOSING OF ENOXAPARIN (ENOX) IN TERM AND PRETERM NEONATES
Chan A.	-	TPA IN CHILDREN WITH ARTERIAL ISCHEMIC STROKE: CASES FROM THE IPSS COMPARED WITH LITERATURE-BASED CASES
Chanchlani S.	-	A ROLE FOR ADIPONENCTIN IN HUMAN PLATELET FUNCTION?
Chander C.L.	-	FLOVAGATRAN (TGN 255), BIVALIRUDIN AND MELAGATRAN - DIFFERENTIAL PHARMACOLOGICAL EFFECTS ON THROMBIN GENERATION
Chandramouli A.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Chandy M.	-	MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
Chang C.H.	-	FCGAMMARII MEDIATES PLATELET AGGREGATION CAUSED BY DISINTEGRINS AND GPIIB/IIIA MONOCLONAL ANTIBODY, AP2
Chang G.	-	ANTITHROMBIC EFFECT OF DJW ON PLATELET-ACTIVATING FACTOR-INDUCED PLATELET AGGREGATION
Chang M.C.	-	INDUCTION OF PLATELET AGGREGATION BY SAS CANCER CELLS A MECHANISM FOR HEMATOGENOUS METASTASIS OF TONGUE CANCER
Chang C.H.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Chang L.Y.	-	A NEW CONVENIENT METHOD FOR FIBRINOGEN PURIFICATION BASED ON THE AFFINITY OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A TO FIBRINOGEN
Chang C.H.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Chang S.	-	EARLY EXCLUSION OF MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN BY TROPONIN I IN CONJUNCTION WITH D-DIMER
Chang Y.W.	-	SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE
Chang J.Y.	-	ENGINEERING A CHIMERIC SERINE PROTEASE INHIBITOR AS A PREVENTATIVE THERAPEUTIC FOR CARDIOVASCULAR DISEASE
Chang C.H.	-	THE INTERACTION OF KERATINOCYTES AND FIBROBLASTS WITH INTEGRIN ALPHA2BETA1 AGONIST, AGGRETIN, AND ITS REGULATION BETWEEN EPITHELIAL/MESENCHYMAL COMMUNICATION
Chang S.T.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Chang C.C.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Chang C.S.	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Chang H.H.	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Chang J.Y.	-	GLYCOSYLATION OF THE ACTIVATION PEPTIDE OF FACTOR IX DETERMINES PLASMA HALF-LIFE
Chang M.C.	-	ANTIPLATELET EFFECTS OF HYDROXYCHAVICOL, A BETEL LEAF COMPONENT
Chang C.C.	-	EXTREMITY NEOPLASM IN PATIENTS WITH HAEMOPHILIA: EXPERIENCE IN MANAGING AN ADOLESCENT WITH MULTICENTRIC GIANT CELL TUMORS
Chang S.T.	-	EXTREMITY NEOPLASM IN PATIENTS WITH HAEMOPHILIA: EXPERIENCE IN MANAGING AN ADOLESCENT WITH MULTICENTRIC GIANT CELL TUMORS
Chang C.H.	-	SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Chang Y.	-	THE NEGATIVE EFFECT OF LEVOBUPIVACAINE ON COLLAGEN-INDUCED PLATELET AGGREGATION
Chang T.T.	-	VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS: RELATION TO BLOOD TRANSFUSION
Chang M.	-	THE INFLUENCE OF THE HEMODIALYSIS PROCEDURES ON PLATELET AND HEMOSTATIC FUNCTIONS
Chanos A.	-	COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE
Chantarangkul V.	-	EVALUATION OF THE THROMBOELASTOMETRY
	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
	-	INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY
	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
Chao H.	-	TOLERANCE INDUCTION TO FIX IN MICE WITH PRE-EXISTING ANTI-FIX IMMUNITY FOLLOWING DIRECT INTRAMUSCULAR INJECTION OF AAV
Chao T.Y.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Chao T.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Chao H.	-	EFFICIENT INDUCTION OF IMMUNE TOLERANCE TO FIX FOLLOWING DIRECT INTRAMUSCULAR GENE TRANSFER
	-	INDUCTION OF FIX TOLERANCE BY DIRECT INTRAMUSCULAR INJECTION OF AAV IS AAV-DOSE/FIX-LEVEL DEPENDENT
Chaos N.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Chapman H.	-	RECOMBINANT IL-11 INCREASES VWF AND VWFMRNA IN TYPE 1 VWD
Chapman W.	-	PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Chapman O.	-	A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
Chapman-Montgomery S.	-	EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION
Chap-Marshak D.	-	COAGULATION PARAMETERS IN AMNIOTIC FLUID DURING HUMAN PREGNANCY ROLE OF TF AND TFPI
Chareyre C.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Charles P.C.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Charpiot P.	-	PRETERM BIRTH AND FETAL GROWTH RESTRICTION HAVE AN IMPACT ON ELASTIC AND COLLAGENIC STRUCTURES OF HUMAN UMBILICAL ARTERIES
Chassany O.	-	D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
Chatard B.	-	THROMBIN GENERATING CAPACITY IS HIGHLY DECREASED AND DELAYED IN PATIENTS WITH VON WILLEBRAND DISEASE
Chaturvedi N.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Chatziioannidis H.	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Chauhan A.K.	-	PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS
	-	ABSENCE OF ADAMTS13 ON A VWF DEFICIENT BACKGROUND IS NO LONGER PROTHROMBOTIC IN A MURINE MODEL OF ARTERIAL THROMBOSIS
	-	CHARACTERIZATION OF THE ROLE OF PLATELET ADHESION MOLECULES IN A MURINE MODEL OF PHOTOSENSITIZER-INDUCED STROKE
	-	PROTHROMBOTIC EFFECTS OF FIBRONECTIN ISOFORMS CONTAINING THE EDA DOMAIN
Chavez L.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Chazouillères O.	-	A NEW MODE OF PROTHROMBIN TIME (PT) REPORTING SPECIFIC FOR LIVER DISEASES
Chediak J.	-	A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B
Chegeni R.	-	FACTOR V MUTATIONS IN IRANIAN PATIENTS WITH ACTIVATED PROTEIN C RESISTANCE AND VENOUS THROMBOSIS
Cheli Y.	-	THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS
	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
	-	INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
Chen D.	-	HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
	-	A PATIENT WITH A MAJOR CARBOXYPEPTIDASE N DEFICIENCY BUT WITH NORMAL PROCARBOXYPEPTIDASE U (TAFI) SERUM LEVEL
Chen P.	-	THE REGULATION OF THROMBOMODULIN DISTRIBUTION IN ENDOTHELIAL CELLS
Chen D.	-	THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY
	-	NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1
Chen C.	-	EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
Chen Z.	-	CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
	-	SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Chen X.	-	SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Chen D.	-	NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT
Chen J.	-	GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
Chen D.	-	A HIGHLY-SENSITIVE PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY BY FLOW CYTOMETRY
Chen F.	-	TRANSDUCTION OF COLONIC EPITHELIUM IN SEVERE HEMOPHILIA B BY NONINVASIVE APPROACH WITH RAAV2-HFIX RESULTED IN TRANSIENT EXPRESSION
Chen Y.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Chen H.	-	INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS
Chen Y.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Chen M.	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Chen Y.	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Chen H.	-	A NOVEL DELETION MUTATION (C.1254 DEL33BP OR C.1251DEL33BP) IN THE F13A GENE CAUSING SEVERE FACTOR XIII DEFICIENCY
Chen X.	-	INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Chen Z.	-	INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
	-	THE HUMAN DNMTS1,3A AND 3B MRNA EXPRESSION IN ADULT ITP PATIENTS
Chen P.	-	IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
Chen F.	-	MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
Chen T.	-	IMPAIRED RESPONSIVENESS OF PLATELETS TO EPINEPHRINE IN CHINESE RELATED TO A2A ADRENOCEPTOR POLYMORPHISMS
Chen Y.C.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Chen H.	-	OCCURRENCE, SUBSTRATE SPECIFICITY, CLONING AND BIOINFORMATIC ANALYSES OF HEMORRHAGIC P-III PROTEASE OF RUSSELL'S VIPER VENOM
Chen L.	-	MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Chen J.	-	EARLY EXCLUSION OF MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN BY TROPONIN I IN CONJUNCTION WITH D-DIMER
Chen Y.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Chen I.S.	-	A NATURAL EXTRACT FROM PIPER PHILIPPINUM (2R,3R)-2-(3',4'-DEHYDROXYBENZYL)-3-(3"-4"-DIMETHOXYBENZYL)BUTYROLACTONE (PP-6) SUPPRESS FMLP-INDUCED SUPDROXIDE PRODUCTION BY INHIBITION FMLP-RECEPTOR BINDING IN HUMAN NEUTORPHIS
Chen V.M.	-	PLATELET ACTIVATION TRIGGERS ACTIVATION OF THE TISSUE FACTOR REGULATOR, PROTEIN DISULPHIDE ISOMERASE
Chen P.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
Chen L.	-	THE RGD-CONTAINING PEPTIDE DERIVED FROM PLATELET DISABLED-2 INHIBITS DU145 PROSTATE CANCER CELL-INDUCED PLATELET AGGREGATION
Chen Y.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
Chen Q.	-	THE ASSOCIATION OF DEPRESSION WITH PLATELET ACTIVATION: EVIDENCE FOR A TREATMENT EFFECT
Chenet C.	-	NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Cheng S.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
Cheng J.	-	THE RGD-CONTAINING PEPTIDE DERIVED FROM PLATELET DISABLED-2 INHIBITS DU145 PROSTATE CANCER CELL-INDUCED PLATELET AGGREGATION
Cheng S.	-	BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
Cheng S.N.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Cheng H.J.	-	A NEW CONVENIENT METHOD FOR FIBRINOGEN PURIFICATION BASED ON THE AFFINITY OF STAPHYLOCOCCUS AUREUS CLUMPING FACTOR A TO FIBRINOGEN
Cheng J.	-	PLATELET PROTEIN DISABLED-2 IS REQUIRED FOR EMBRYONIC STEM CELL-DERIVED MESODERM FORMATION AND MEGAKARYOCYTIC DIFFERENTIATION
Cheng S.	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Cheng G.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Cheng Q.	-	REDUCED MORTALITY OF PERITONEAL SEPSIS IN FACTOR XI DEFICIENT MICE
Cherel G.	-	ROLE OF THE ALPHA-HELIX 163-170 IN FACTOR XA CATALYTIC ACTIVITY
Chereshnev I.	-	NATURALLY OCCURRING TF VARIANTS ARE PRESENT IN BLOOD OF FVB/N MICE: THE MKR MODEL OF TYPE 2 DIABETES IS WELL SUITED FOR DEVELOPMENT OF A TF-BASED MODEL OF DIABETIC THROMBOPHILIA
Cherian S.	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Cherian V.M.	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
Cherkas L.F.	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
Chernookov A.I.	-	HYPERHOMOCYSTEINEMIA AND FACTOR V LEIDEN ACT SYNERGISTICALLY INCREASING RISK OF VEIN THROMBOSIS IN NORTH-WESTERN RUSSIA
Chernova T.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Chernukha E.A.	-	RECOMBINANT COAGULATION FACTOR VIIA IN THERAPY OF MASSIVE POST-PARTUM BLEEDING AT PATIENT WITH IDIOPATHIC THROMBOCYTOPENIA (ITP)
Cherrick I.	-	POST-THROMBOTIC SYNDROME IN CHILDREN SURVIVING ACUTE LYMPHOBLASTIC LEUKEMIA
Chesnokova N.B.	-	FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
Chevreaud C.	-	A NOVEL DYSFIBRINOGENEMIA DETECTED BY ELECTROPHORESIS IN A PATIENT PRESENTING WITH FAMILIAL VENOUS THROMBOEMBOLISM
Chew H.	-	CAUSE OF DEATH AMONG PATIENTS WITH LOCAL OR REGIONAL STAGE CANCER OF THE BREAST AND LUNG WHO DEVELOP VENOUS THROMBOEMBOLISM (VTE)
	-	VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
Cheyne E.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
Chi H.	-	ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
Chi C.	-	POSTPARTUM LOCHIAL LOSS IN WOMEN WITH INHERITED BLEEDING DISORDERS
	-	LONG TERM FOLLOW-UP OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN THE MANAGEMENT OF MENORRHAGIA IN WOMEN WITH INHERITED BLEEDING DISORDERS
	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Chi H.	-	PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Chianelli M.	-	EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
Chiang J.L.	-	EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
Chiang J.	-	PREVALENCE OF VON WILLEBRAND'S DISEASE IN PREMENOPAUSAL WOMEN WITH IRON DEFICIENCY ANEMIA AND MENORRHAGIA
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
	-	GENETIC DEFECT DETECTION OF HEMOPHILIA A BY LONG RANGE POLYMERASE CHAIN REACTION AND DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY
Chicanne G.	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
Chien S.	-	MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Chieng-Yane P.	-	THE THROMBIN ENDOTHELIAL RECEPTORS, THROMBOMODULIN AND PAR-1, ACTIVATE EGF RECEPTOR THROUGH DISTINCT SIGNALLING
Chil R.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Chiles P.G.	-	HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
	-	HETEROZYGOUS FIBRINOGEN GAMMA-114 TYR-HIS MUTATION ASSOCIATED WITH RESISTANCE TO TPA-MEDIATED FIBRINOLYSIS AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Chinchen S.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Chin-Dusting J.	-	FERRIC CHLORIDE INDUCES VASCULAR INJURY AND THROMBOSIS BY OXIDATIVE INJURY TO RED BLOOD CELLS
	-	ENDOTHELIAL CELL TYPE AND ACTIVATION STATE AFFECTS SOLUBLE P-SELECTIN MEDIATED LEUKOCYTE ADHESION
Chinni E.	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
Chinni E.E.C.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Chinthammitr Y.	-	INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND
Chion C.K.N.K.	-	FURTHER CHARACTERISATION OF ADAMTS13 INACTIVATION BY THROMBIN
	-	EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS
	-	EVIDENCE FOR TWO FUNCTIONAL CALCIUM-BINDING SITES ON ADAMTS13
Chion A.	-	VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
	-	N-LINKED GLYCOSYLATION OF VWF MODULATES THE INTERACTION WITH ADAMTS13
Chion C.K.N.K.	-	VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
	-	NON-CONSERVED/VARIABLE REGIONS IN THE ADAMTS13 METALLOPROTEINASE DOMAIN ARE DETERMINANTS OF SUBSTRATE SPECIFICITY
Chiou S.S.	-	VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS: RELATION TO BLOOD TRANSFUSION
Chirinian Y.	-	EXERCISE IMPROVES THE GLOBAL HEMOSTATIC EFFICACY IN SEVERE HEMOPHILIA A DOGS, AS DETERMINED BY THROMBELASTOGRAPHY
	-	THE INFLUENCE OF INTRON 1 SEQUENCE VARIATIONS IN MUTATION- NEGATIVE TYPE 1 VON WILLEBRAND DISEASE PATIENTS
	-	THE PREVALENCE OF SYMPTOMATIC VON WILLEBRAND DISEASE (VWD) IN PRIMARY CARE PRACTICE
Chirino N.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Chiriu A.	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
Chirivella M.	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
Chishti A.H.	-	TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN
Chitlur M.	-	TISSUE PLASMINOGEN ACTIVATOR (RTPA) INDUCED FIBRINOLYSIS - STANDARDIZATION OF METHOD ON THROMBELASTOGRAPHY
Chitlur M.B.	-	FIBRINOLYTIC PARAMETERS IN CHILDREN WITH NON-CATHETER RELATED DEEP VENOUS THROMBOSIS
Chitlur M.	-	INFLUENCE OF NANOPOLYMERS WITH DIFFERENT END-FUNCTIONALITIES ON PLATELETS AND COAGULATION. AN EX-VIVO STUDY
Chiu J.	-	MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
Chiu T.	-	EARLY EXCLUSION OF MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN BY TROPONIN I IN CONJUNCTION WITH D-DIMER
Chiu W.	-	CRYO-EM OF MOLECULAR MACHINES AND CELLS
Cho Y.	-	PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Cho J.	-	EXPRESSION OF PROTEIN DISULFIDE ISOMERASE DURING THROMBUS FORMATION
Cho H.	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Cho K.	-	THE INHIBITORY ACTIVITY AND MECHANISM OF BUD-030, A NOVEL INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
Cho Y.	-	ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
Cho M.	-	ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
Cho H.	-	MONITORING OF PLATELET FUNCTION AFTER CLOPIDOGREL TREATMENT
Chodirker L.	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
Choi E.J.	-	IMMUNE TOLERANCE INDUCTION FOR KOREAN HEMOPHILIACS WITH INHIBITORS
Choi H.	-	SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
Choi J.	-	BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING
Choi D.	-	ANALYSIS OF EFFECTS OF METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) POLYMORPHISMS ON HOMOCYSTEINE CONCENTRATION AND RECURRENT SPONTANEOUS ABORTION IN KOREANS
Choi K.	-	KNOWLEDGE AND BEHAVIORS REGARDING COMPLICATION AND PREVENTION OF PATIENTS WITH HEMOPHILA IN KOREA
Choi S.	-	POLYPHOSPHATE ENHANCES FACTOR XII ACTIVATION
Choi K.D.	-	INTERMEDIATE-DOSE PROPHYLAXIS EXPERIENCE FOR KOREAN HEMOPHILIA PATIENTS
Choi K.	-	PREVALENCE OF HEPATITIS B AND C AND ABNORMAL LIVER FUNCTION TESTS IN PATIENTS WITH HEMOPHILIA IN KOREA
Choi W.	-	DISINTEGRIN SUPPRESSES HUMAN VASCULAR ENDOTHELIAL CELL MIGRATION AND INVASION BY REGULATING PLATELET ACTIVATION
Chollet M.	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
Chomienne C.	-	HETEROGENEITY OF ESSENTIAL THROMBOCYTHEMIA: VARIABLE EXPRESSION OF THE V617F JAK2 MUTATION AND THE PLATELET CD36 LEVEL. NO ASSOCIATION WITH THROMBOTIC MANIFESTATIONS
Chong N.	-	PAI-1 IN PLATELETS IS DEPENDENT ON THE 4G/5G POLYMORPHISM
	-	PLATELETS INDUCE PAI-1 GENE EXPRESSION IN MONOCYTES THROUGH TGF-BETA
Chong S.S.Y.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
	-	EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
Choolani M.	-	HUMAN TISSUE KALLIKREINS, HK6 AND HK10 AS NOVEL BIOMARKERS FOR EPITHELIAL OVARIAN CANCER
Choowongkomon K.	-	PROTEIN C MUTATIONS IN THAI PATIENTS WITH VENOUS THROMBOEMBOLISM
Chotsuppakarn S.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
Chou E.	-	MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
Chou F.	-	RECOMBINANT HUMAN THROMBOMODULIN PROMOTES SMOOTH MUSCLE CELL MIGRATION
Chouery E.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Chow T.Y.K.	-	PROCOAGULANT EFFECT OF DEXAMETHASONE IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: A POTENTIAL MECHANISM OF GLUCOCORTICOID-INDUCED OSTEONECROSIS
Chowdary P.	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
	-	CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ISOLATED ANTI-BETA2 GLYCOPROTEIN I ANTIBODY POSITIVITY
	-	THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
Chrétien J.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Christ G.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Christensen S.	-	THE DIFFERENTIAL EFFECTS OF ACIDOSIS ON FIBRINOGEN SYNTHESIS AND DEGRADATION IN PIGS
Christensen M.S.	-	INVESTIGATION OF HUMAN RECOMBINANT FVIIA METABOLISM IN A PERFUSED RAT LIVER MODEL
Christensen K.	-	PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS?
Christersson C.	-	ADP INDUCED TF PRODUCTION BY FORMATION OF PLATELET-MONOCYTE AGGREGATES IS NOT EFFECTED BY DIRECT THROMBIN INHIBITORS
Christiaens L.	-	ASPIRIN PREVENTS PLATELET ACTIVATION AFTER CORONARY ARTERY BYPASS SURGERY DESPITE AN INCREASE IN THROMBOXANE A2 SYNTHESIS
Christiansen S.C.	-	ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
Christiansen K.	-	EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
	-	DETECTION OF FUNCTIONAL FACTOR VII INHIBITORS IN PLASMA
Christiansen S.C.	-	THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER
Christiansen K.	-	ROTEM THROMBELASTOMETRY ANALYTICAL CONTROL, VARIATION, AND VALIDATION USING A FROZEN PLATELET RICH PLASMA CONTROL AND ACTIVATION WITH MINUTE AMOUNTS OF TISSUE FACTOR
Christiansen S.C.	-	HOMOCYSTEINE AND RISK FOR VENOUS THROMBOSIS IN A POPULATION-BASED PROSPECTIVE STUDY (HUNT2)
Christophe N.	-	THE IMPORTANCE OF TYPE OF QUALITY CONTROL WHEN CHANGING REAGENT BATCHES
Christophe O.D.	-	A MURINE MODEL TO ASSESS VON WILLEBRAND FACTOR FUNCTION IN VIVO
	-	CHARACTERIZATION OF THE INTERACTION BETWEEN VON WILLEBRAND FACTOR AND OSTEOPROTEGERIN
	-	ROLE OF THE ALPHA-HELIX 163-170 IN FACTOR XA CATALYTIC ACTIVITY
Christophe O.	-	KINETICS OF HYDROLYSIS BY FVIII HYDROLYZING ANTIBODIES IN ACQUIRED HEMOPHILIA A
	-	IGG ANTIBODIES WITH HYDROLYTIC ACTIVITY TOWARDS ENDOGENOUS FVIII IN A FRENCH COHORT OF PATIENTS WITH ACQUIRED HEMOPHILIA
Christopherson P.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Christopoulou-Kokkinou V.	-	HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
Chrostek A.	-	DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
Chrousos G.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
Chrzanowska-Wodnicka M.	-	RAP1B IS REQUIRED FOR NORMAL ANGIOGENESIS AND MAPK SIGNALING IN ENDOTHELIAL CELLS
Chtourou S.	-	CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
	-	COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A
	-	EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
	-	ANALYZE OF THE CO-PURIFIED PROTEINS WITH A HIGHLY PURIFIED PLASMA-DERIVED FACTOR VIII: FVIII-SD-35-15
Chu X.X.	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Chua M.N.	-	CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Chuah M.	-	DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS
Chuah M.K.	-	RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER
Chuamsunrit A.	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
Chuansumrit A.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Chudy P.	-	ACQUIRED HAEMOPHILIA A WITH INHIBITOR - CASE REPORT
	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
Chudzinski Tavassi A.M.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Chudzinski-Tavassi A.M.	-	CLONING, ANALYSIS AND STRUCTURAL PREDICTION OF LOSAC, A NEW HEMOLIN FROM LONOMIA OBLIQUA
	-	AMBLYOMIN-X IN CULTURED CANCER CELLS: CITOTOXICITY AND CELL CYCLE EFFECTS
Chumpia W.	-	PROTEIN C MUTATIONS IN THAI PATIENTS WITH VENOUS THROMBOEMBOLISM
Chung H.	-	ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
Chung J.Y.	-	LIVING DONOR LIVER TRANSPLANTATION FOR HBV-ASSOCIATED HEPATOMA IN A HEMOPHILIC PATIENT
Chung T.Y.	-	SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
Chung K.	-	THE INHIBITORY ACTIVITY AND MECHANISM OF BUD-030, A NOVEL INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
Chung F.	-	INHIBITION OF AIRWAY SMOOTH MUSCLE CELL ADHESION AND MIGRATION BY THE DISINTEGRIN DOMAIN OF ADAM-15
Chung K.	-	ANTITHROMBOTIC EFFECT OF RECOMBINANT DISINTEGRIN IN A MOUSE THROMBOSIS MODEL
Chung C.Y.	-	SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
Chung D.W.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Chung C.H.	-	THE INTERACTION OF KERATINOCYTES AND FIBROBLASTS WITH INTEGRIN ALPHA2BETA1 AGONIST, AGGRETIN, AND ITS REGULATION BETWEEN EPITHELIAL/MESENCHYMAL COMMUNICATION
Chung T.Y.	-	NOVEL MUTATIONS IN THE FACTOR V GENE OF TAIWANESE FACTOR V DEFICIENCY PATIENTS
Chung J.	-	1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Chung C.H.	-	ANTIPLATELET AND ANTITHROMBOTIC ACTIVITY OF NP-313, 2-ACETYLAMINO-3-CHLORO-1,4-NAPHTHOQUINONE, A NOVEL CPLA2 AND CYTOSOLIC CA 2 + MOBILIZATION INHIBITOR
Church F.C.	-	ACTIVATED PROTEIN C HAS BOTH INTRACELLULAR AND EXTRACELLULAR EFFECTS ON BREAST CANCER AND ENDOTHELIAL CELL MIGRATION
	-	ENGINEERING A CHIMERIC SERINE PROTEASE INHIBITOR AS A PREVENTATIVE THERAPEUTIC FOR CARDIOVASCULAR DISEASE
	-	SERPINS IN THROMBOSIS, HEMOSTASIS AND FIBRINOLYSIS
	-	RNA APTAMER-DIRECTED ANTICOAGULANT THERAPY
Chytilová M.	-	NEW HEREDITARY DYSFIBRINOGENEMIA AALPHA ASN106ASP ASSOCIATED WITH THROMBOSIS
Ciabattoni G.	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
Cianci V.	-	SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
Cianflone D.	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Ciani F.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Cichon S.	-	HEREDITARY ANGIOEDEMA TYPE III ARE CAUSED BY A GAIN OF FUNCTION MUTATION IN COAGULATION FACTOR XII, WHICH INCREASES VASCULAR PERMEABILITY MEDIATED BY BRADYKININ GENERATION
Cid A.	-	IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
Cid A.R.	-	INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
Cierniewska-Cieslak A.	-	KU80 AS A NOVEL RECEPTOR FOR THYMOSIN BETA4 THAT MEDIATES ITS INTRACELLULAR ACTIVITY DIFFERENT FROM G ACTIN SEQUESTERING
Cierniewski C.S.	-	KU80 AS A NOVEL RECEPTOR FOR THYMOSIN BETA4 THAT MEDIATES ITS INTRACELLULAR ACTIVITY DIFFERENT FROM G ACTIN SEQUESTERING
	-	EFFECT OF NATRIURETIC PEPTIDES ON ANGIOGENIC PROPERTIES OF HUMAN ENDOTHELIAL CELLS
	-	INTERACTION AND FUNCTIONAL ASSOCIATION OF PROTEIN-DISULFIDE ISOMERASE WITH V3 INTEGRIN ON ENDOTHELIAL CELLS
	-	REGULATORY EFFECT OF ALPHA1-ACID GLYCOPROTEIN ON PAI-1 REDISTRIBUTION ON ENDOTHELIAL CELLS SURFACE
Ciftci A.	-	THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Cifuni S.M.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Cigna V.	-	PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY
	-	THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE
	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
Cimenti C.	-	THROMBIN GENERATION IN OBESE CHILDREN AFTER WEIGHT REDUCTION
Cimino E.	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
Cimminiello C.	-	D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY
Cimon K.	-	ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
Cines D.B.	-	THE ROLE OF HIT PLATELET FACTOR 4 ANTIGENIC COMPLEXES ON MONOCYTE SURFACES IN THE PATHOGENESIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	PARTIAL FIBRIN ADHESION AND DIFFUSION SUGGESTED RETEPLASE AS THE THERAPEUTIC CHOICE FOR CATHETER DRIVEN THROMBOLYSIS
Cini M.	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
Cinotti S.	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
Cipolla A.	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
Cirillo F.	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS
	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
Cirioni-Tellier L.	-	MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM
Cirkel U.	-	ESTABLISHING REFERENCE VALUES FOR COAGULATION PARAMETERS IN PREGNANT WOMEN
Ciucciarelli L.	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
Ciuffreda M.	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
Ciuti G.	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
Claessen N.	-	UPAR IS AN IMPORTANT MODULATOR OF TUBULAR REPAIR AFTER RENAL ISCHEMIA REPERFUSION INJURY
Claeyssens S.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
Clark N.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Clark P.	-	THE GOAL STUDY: A PROSPECTIVE EXAMINATION OF THE IMPACT OF FACTOR V LEIDEN AND ABO (H) BLOOD GROUPS ON HAEMORRHAGIC AND THROMBOTIC PREGNANCY OUTCOMES
Clark D.	-	THE CANADIAN RARE INHERITED BLEEDING DISORDERS REGISTRY (RIBDR) OF COAGULATION FACTOR DEFICIENCIES AND PLATELET FUNCTION DISORDERS
Clark N.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Clark P.	-	THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY
Clarke P.	-	URINARY EXCRETION OF VITAMIN K METABOLITES IN TERM AND PRETERM INFANTS
Clarke M.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
Clarke S.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Claudia S.	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
Claus R.A.	-	BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
Claustres M.	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Clayessens S.	-	TREATMENT OF GASTROINTESTINAL BLEEDING AND ANGIODYSPLASIA IN GLANZMANN THROMBASTHENIA WITH OCTREOTIDE
Cleary D.B.	-	ROLE OF INDIVIDUAL AMINO ACID POSITIONS IN THE BINDING AND HYDROLYSIS OF GLUTAMINE-CONTAINING SUBSTRATES TO FACTOR XIIIA
Clements M.L.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Clemetson J.	-	DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME
Clemetson K.	-	DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME
Clemetson K.J.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Clerici M.	-	THROMBIN GENERATION IN SEVERE HEMOPHILIACS WITH DIFFERENT CLINICAL PHENOTYPE
	-	THE ENDOGENOUS THROMBIN POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM
Cleto E.	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
Cleutjens J.P.M.	-	DUAL EFFECT OF PLATELET-DERIVED MATRIX METALLOPROTEINASES ON OCCLUSIVE THROMBUS GROWTH
Clijsters P.P.	-	THE MARBURG-1 MUTATION REDUCES THE AUTOCATALYTIC ACTIVITY OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP)
Climent V.	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
Clofent Sanchez G.	-	ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Clutterbuck R.	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC CELL-BASED APPROACH
Clutterbuck R.D.	-	THE INHIBITORY ACTIVITY OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ON BREAST CARCINOMA CELL LINES
Clutterbuck R.	-	BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
Clutterbuck R.D.	-	SYNERGISTIC EFFECT OF HEPARIN, LOW MOLECULAR WEIGHT HEPARIN AND PACLITAXEL ON CYTOTOXICITY FOR BREAST CARCINOMA CELLS IN CULTURE
Coady E.	-	CIRCULATING PLATELET-MONOCYTE COMPLEXES AS POTENTIAL BIOMARKERS OF THE OVERALL ATHEROSCLEROSIS LOAD IN MEN WITH AND WITHOUT KNOWN CORONARY ARTERY DISEASE
Coca M.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Cochery-Nouvellon E.	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
	-	MONOCYTE IL-10 PRODUCED IN RESPONSE TO LPS MODULATES THROMBIN GENERATION BY INHIBITING TISSUE FACTOR EXPRESSION AND RELEASE OF ACTIVE TISSUE FACTOR-BOUND MICROPARTICLES
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
Cocho D.	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Cochrane A.	-	MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
Cocomazzi N.	-	A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY
	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Codd V.	-	PLATELETS INDUCE PAI-1 GENE EXPRESSION IN MONOCYTES THROUGH TGF-BETA
Coen Herak D.	-	ACL TOP PERFORMANCE IN ROUTINE COAGULATION TESTING
	-	INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
	-	SENSITIVITY OF THE PLATELET FUNCTION ANALYZER (PFA-100) AS A SCREENING TEST FOR LABORATORY DIAGNOSIS OF VON WILLEBRAND DISEASE
Coenen M.J.	-	ANALYSIS OF FOLATE-RELATED GENES FOR ASSOCIATION WITH PLASMA HOMOCYSTEINE LEVEL IN A SNP-MICROARRAY APPROACH
Coffey A.J.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Cohen H.	-	PREGNANCY MORBIDITY IS ASSOCIATED WITH LOW PLASMA TISSUE FACTOR PATHWAY INHIBITOR LEVELS, INCREASED THROMBIN GENERATION AND RESISTANCE TO ACTIVATED PROTEIN C
Cohen A.T.	-	CLINICAL EFFICACY AND SAFETY OF FONDAPARINUX IN PATIENTS WITH CONGESTIVE HEART FAILURE (CHF): A SUBANALYSIS OF THE RANDOMIZED ARTEMIS TRIAL
Cohen E.	-	POST - CORONARY INTERVENTION RECURRENT ISCHEMIA IN THE PRESENCE OF ADEQUATE PLATELET INHIBITION BY DUAL ANTIPLATELET THERAPY: WHAT ARE WE OVERLOOKING?
Cohen H.	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS)
Cohen A.T.	-	THE PREVALENCE AND BURDEN OF VENOUS THROMBOEMBOLIC DISEASE (VTE) IN SURGICAL PATIENTS IN EUROPE: DATA FROM THE VITAE STUDY
	-	LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
Cohen H.	-	TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA WITH MABTHERA (RITUXIMAB)
Cohen A.T.	-	EFFICACY OF FONDAPARINUX IN MEDICAL PATIENTS WITH RESTRICTED MOBILITY ACCORDING TO THE ENDPOINT PROPOSED BY THE EUROPEAN COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
Cohen H.	-	SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME
	-	ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC
	-	MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN
Cohn E.F.	-	INDUCTION OF FIX TOLERANCE BY DIRECT INTRAMUSCULAR INJECTION OF AAV IS AAV-DOSE/FIX-LEVEL DEPENDENT
Cohn D.M.	-	NECESSITY OF SCREENING FOR THROMBOPHILIA AT DIAGNOSIS OF VENOUS THROMBOEMBOLISM: OUTLINE OF THE NOSTRADAMUS INTERVENTION TRIAL
Cohn E.F.	-	EFFICIENT INDUCTION OF IMMUNE TOLERANCE TO FIX FOLLOWING DIRECT INTRAMUSCULAR GENE TRANSFER
	-	TOLERANCE INDUCTION TO FIX IN MICE WITH PRE-EXISTING ANTI-FIX IMMUNITY FOLLOWING DIRECT INTRAMUSCULAR INJECTION OF AAV
Colageo E.	-	SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
Colaizzo D.	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
	-	A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS
Colangelo I.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Colao A.	-	LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
Colden-Stanfield M.	-	ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION
Cole S.A.	-	GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN
Colgan O.C.	-	A DYNAMIC MODEL OF THE BLOOD-BRAIN BARRIER
Colicchia A.	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Colina C.M.	-	TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
Coll E.	-	HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS
Coll I.	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Coll E.	-	IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Collen D.	-	DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS
Collet C.	-	BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
Collet J.	-	COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Collet J.P.	-	PROTEIN Z LEVEL AND GENE POLYMORPHISMS IN MYOCARDIAL INFARCTION IN THE YOUNG
Colli S.	-	PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1
	-	CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS
	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
Collier M.E.W.	-	THE ABILITY OF TF TO PROMOTE TUMOUR CELL IMMUNE EVASION, MEDIATED VIA SURFACE VCAM-1
	-	DIFFERENTIAL EXPRESSION OF TF IN CARDIAC HYPERTROPHY AND ITS INVOLVEMENT IN THE PROGRESSION OF THE DISEASE
	-	THE INFLUENCE OF TISSUE FACTOR ON OESTROGEN RECEPTOR ALPHA EXPRESSION AND CELL INVASION IN BREAST CANCER CELLS
Collins P.	-	BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
	-	BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
Collins R.	-	CONTRAINDICATIONS TO ANTICOAGULANTS ARE COMMON IN PATIENTS REQUIRING VENOUS THROMBOEMBOLISM PROPHYLAXIS
Collins D.A.	-	ELTROMBOPAG, THE ORAL PLATELET GROWTH FACTOR, INCREASED PLATELET COUNT AND DID NOT AFFECT PLATELET FUNCTION WHEN ADMINISTERED TO HEALTHY MALE SUBJECTS
Collins R.	-	DIFFERENTIAL VENOUS THROMBOEMBOLISM PROPHYLAXIS PRESCRIPTION IN PATIENTS WITH SURGICAL AND NON-SURGICAL CONDITIONS ADMITTED TO SURGICAL UNITS
Collins R.D.	-	IMPLEMENTATION OF SYSTEM CHANGE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS
Collins P.B.	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Collins R.	-	THE IMPLEMENTATION OF A NURSE SPECIALIST MODEL OF CARE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS RATES IN MEDICAL AND SURGICAL PATIENTS
Collins P.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Collot-Teixeira S.	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
Colman R.W.	-	CLEAVED HIGH MOLECULAR WEIGHT KININOGEN (HKA) STIMULATES EXPRESSION OF MONOCYTE TISSUE FACTOR (TF) DEPENDENT ON SECRETION OF CYTOKINES AND CHEMOKINES
	-	CLEAVED KININOGEN INHIBITS ANGIOGENESIS BY TARGETING ENDOTHELIAL CAVEOLAE
	-	DOMAIN 5 PEPTIDES OF HIGH MOLECULAR MASS KININOGEN UNDERGO CONFORMATIONAL CHANGES INDUCED BY ZINC
Colnago D.	-	ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
Colognesi I.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Colombo A.	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
Colombo M.	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
Colombo A.	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
Colon J.	-	IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION
Colonna S.	-	THROMBOPHILIA IN PATIENTS WITH CRYPTOGENETIC STROKE AND PATENT FORAMEN OVALE
Colorado M.	-	RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Colovic M.	-	MOLECULAR MARKERS OF BLOOD HYPERCOAGULABILITY IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN MUTATION
Coltat J.	-	FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
Colucci M.	-	HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH APC RESISTANCE
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	IN VITRO INHIBITION OF MONOCYTE TISSUE FACTOR AND PAI-2 PRODUCTION BY OCHRATOXIN A
	-	LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
	-	MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
Colvin S.	-	CHANGES IN THROMBIN GENERATION KINETICS FOLLOWING HEMORRHAGIC SHOCK AND RESUSCITATION IN PIGS
Combe S.	-	PR-15 A NOVEL INTRAVENOUS INHIBITOR OF PLATELET ADHESION: A PHASE I DOSE ASCENDING PHARMACOKINETIC, PHARMACODYNAMIC, AND TOLERANCE STUDY
Combescures C.	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
Combettes L.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Combrié R.	-	PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
	-	HETEROGENEITY WITHIN THE PROTEIN CONTENT OF SECRETORY ORGANELLES OF HUMAN PLATELETS
Comerota A.J.	-	THE PRIORITY TRIAL: PLASMIN REVASCULARIZATION OF ACUTE LOWER EXTREMITY NATIVE ARTERY OR BYPASS GRAFT OCCLUSIONPHASE I/II PROTOCOL DESIGN
Cominetti M.R.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Comp P.C.	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Companys E.	-	CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
	-	MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
Conard J.	-	SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
	-	IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES
	-	D-DIMER MEASUREMENT AND THROMBOPHILIA SCREENING IN THE FOLLOW-UP OF PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
Concepcion A.	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Concolato A.	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
Concordet D.	-	ESTIMATING THE INFLUENCE OF MEASUREMENT VARIABILITY ON DIAGNOSTIC ERRORS: A BAYESIAN MODEL APPLIED TO QUANTITATIVE D DIMER ASSAYS FOR THE EXCLUSION OF VENOUS THROMBOSIS
Conejeros W.M.	-	D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION
Coneska B.	-	A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
Conkie J.	-	PREDICTING RISK OF RECURRENT VENOUS THROMBOSIS USING A 5-POINT SCORING SYSTEM INCLUDING FIBRIN D-DIMER
Conley P.B.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
	-	PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
Connor J.H.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Connor R.F.	-	DYNAMICS OF DISINTEGRIN DISRUPTION OF INTEGRIN STRUCTURE AND FUNCTION
Conradi F.	-	EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
Conti E.	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
Conti S.	-	HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Conti-Kelly A.	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
Conway E.M.	-	THROMBOMODULIN - GUARDING THE VASCULAR ENDOTHELIUM
Conway J.	-	POINT OF CARE INR MONITORING IN CHILDREN WITH VENTRICULAR ASSIST DEVICES
Conze M.	-	PLATELET RESPONSIVENESS TOWARDS ANTIPLATELET MEDICATIONS BEFORE AND AFTER CORONARY ANGIOGRAPHY AND PERCUTENOUS CORONARY INTERVENTIONS AS DETERMINED BY WHOLE BLOOD AGGREGOMETRY
Cook D.	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Cook P.	-	THE DYNAMICS OF THE BINDING OF PLASMINOGEN AND TPA TO IMMOBILIZED HIGH MOLECULAR WEIGHT FIBRIN DEGRADATION PRODUCTS
Cook R.J.	-	FACTORS INFLUENCING THE ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODY (ANTI-PF4/H AB) IMMUNE RESPONSE: AN ANALYSIS OF FOUR RANDOMIZED CONTROLLED TRIALS (RCT'S) COMPARING ENOXAPARIN (ENOX) TO FONDAPARINUX (FONDA)
Cook L.	-	FREQUENCY OF "SPECIAL POPULATION" CHARACTERISTICS IN VENOUS THROMBOEMBOLISM PATIENTS IN CLINICAL PRACTICE: EFFECT ON PATIENT MANAGEMENT
Cook R.J.	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Cooke V.G.	-	GENETIC ABLATION OF JAM-A IMPAIRS SURVIVAL AFTER MYOCARDIAL INFARCT
Cooke M.	-	KLF4, A MODIFIER GENE IN GP6-NULL MICE
Cooke P.	-	THE USE OF THE WARKENTIN ET AL 4T CLINICAL SCORING SYSTEM TO DETERMINE PROSPECTIVELY THE APPROPRIATENESS OF HIT ANTIBODY TESTING AT THE REGIONAL HAEMOSTASIS LABORATORY, BELFAST CITY HOSPITAL, N IRELAND
Cooney M.T.	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Cooper P.C.	-	SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
Cooper A.J.	-	TFPI PLASMA LEVELS IN WOMEN WITH PRE-ECLAMPSIA
Cooper P.C.	-	SENSITIVITY OF THE HEMOSIL THROMBOPATH ASSAY TO DEFECTS IN THE PROTEIN C ANTICOAGULANT PATHWAY
	-	EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
Cooper S.M.	-	EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
Cooper M.E.	-	HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
Cooper P.C.	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
	-	COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A
	-	THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF)
	-	IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
Cooper A.J.	-	PLASMA THROMBOMODULIN IN PRE-ECLAMPSIA
Coppens M.	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	JAK2-V617F IS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
	-	PREVENTION OF TRAVELLERS' THROMBOSIS: A COMPARISON OF THREE INTERVENTIONS THAT PROMOTE VENOUS OUTFLOW
	-	INFLUENCE OF TESTING FOR INHERITED THROMBOPHILIA ON RECURRENCE OF VENOUS THROMBOEMBOLISM
	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
Coppola A.	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
Coppola D.	-	DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION
Coppola A.	-	IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY
	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
	-	ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	FVIII/VWF CONCENTRATE FOR IMMUNE TOLERANCE INDUCTION (ITI) IN ITALIAN HAEMOPHILIACS WITH NEGATIVE PREDICTORS OF ITI RESPONSE
Corazzi T.	-	RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES
Corbani S.	-	DETECTION OF 23 NOVEL MUTATIONS IN LEBANESE HEMOPHILIA PATIENTS
Corbella M.	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Corbillón L.	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Corcione A.	-	CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Cordeiro A.L.	-	FACTOR V LEIDEN AS A THROMBOPHILIA'S MARKER IN LIVER TRANSPLANTATION - AN EVALUATION
Cordell P.A.	-	SECRETION OF COAGULATION FACTOR XIIIA FROM HAEMATOPOIETIC CELLS
Cordova R.	-	GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
Cork W.	-	CLINICAL APPLICATIONS OF A DIRECT GENOMIC PLATFORM FOR SNP DETECTION IN HUMAN DNA SAMPLES USING GOLD NANOPARTICLE PROBE TECHNOLOGY AND ENHANCED SIGNAL AMPLIFICATION
Cornacchini S.	-	ANTIPHOSPHOLIPID SYNDROME AND PORTABLE COAGULOMETERS
	-	PERIODICAL LABORATORY EVALUATION OF PORTABLE COAGULOMETERS
Corno A.R.	-	FALSE UNCOAGULABLE PT-INR RESULTS
Corral J.	-	IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
	-	BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
	-	HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Correa B.T.	-	807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
Correa G.	-	ABNORMAL PATTERN FOR FVIII GENE INTRON 1 INVERSION IN ONE BRAZILIAN FAMILY
Corrigan N.	-	S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
Corrocher R.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Corsi J.	-	CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA
Corsi A.	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
Corsi A.M.	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
Corsi A.	-	QUALITY OF OAT AND VTE RECURRENCE
Cortellaro M.	-	E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
Cortes R.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Cortez P.	-	IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
Cortina V.	-	INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
Corvazier E.	-	CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Cosemans J.M.E.M.	-	DUAL EFFECT OF PLATELET-DERIVED MATRIX METALLOPROTEINASES ON OCCLUSIVE THROMBUS GROWTH
	-	INHIBITION OF P2Y12 BY AZD6140 REDUCES THROMBUS FORMATION AND PROCOAGULANT ACTIVITY ON COLLAGEN AND ATHEROSCLEROTIC PLAQUES
	-	SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
Cosin R.	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
Cosmi B.	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	RESIDUAL VENOUS OBSTRUCTION AND D-DIMER AS RISK FACTORS FOR RECURRENCE AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
	-	HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
Costa D.S.P.	-	THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS
Costa J.M.	-	THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE
Costagliola D.	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Costanzo S.	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
	-	DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK?
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
Coste P.	-	ABCIXIMAB-DEPENDENT THROMBOCYTOPENIA IN PATIENTS WITH ACUTE CORONARY SYNDROMES CAN OCCUR BY DIFFERENT MECHANISMS
Cotes D.J.	-	THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) FOLLOWING CARDIAC SURGERY: AN EMERGING SYNDROME
Cotrina R.Y.	-	REAL EFFECT OF WARFARIN THERAPY PREVENTING STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
Coughlin P.	-	CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
Coughlin S.R.	-	PROTEASE-ACTIVATED RECEPTORS IN HEALTH AND DISEASE
Coughlin P.B.	-	DESMOTEPLASE-MEDIATED PLASMINOGEN ACTIVATION AND CLOT LYSIS ARE ANTAGONIZED BY THE LYSINE ANALOGUE TRANEXAMIC ACID
Couper R.	-	THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
Cournoyer D.	-	PROCOAGULANT EFFECT OF DEXAMETHASONE IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS: A POTENTIAL MECHANISM OF GLUCOCORTICOID-INDUCED OSTEONECROSIS
Courtney D.M.	-	Prospective Evaluation of a Quantitative D-dimer for Pulmonary Embolism: is Structured Pretest Probability Assessment Always Needed?
	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Cousin L.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
Couturaud F.	-	DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN
	-	BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
Couty M.	-	COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Covic L.	-	IDENTIFICATION OF A MICROTUBULE ASSOCIATED PROTEIN, BICAUDAL-D1, AS A NOVEL REGULATOR OF PAR1-G PROTEIN SIGNALING
	-	TUMOR-DERIVED CYR61 PROMOTES STROMAL MATRIX METALLOPROTEINASE PRODUCTION AND ANGIOGENESIS
Covic N.	-	THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Cowan P.	-	MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
	-	INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
Cox P.	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Cox D.	-	A NOVEL GPIB ALPHA BINDING PROTEIN ON STREPTOCOCCUS GORDONII INDUCES PLATELET ROLLING AT LOW SHEAR
Cox S.	-	EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Cox D.	-	PLATELETS AND BACTERIA
	-	STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
	-	USING A PROTEOMIC APPROACH TO IDENTIFY SPECIFIC STREPTOCOCCAL PROTEINS RESPONSIBLE FOR INDUCING PLATELET AGGREGATION IN INFECTIVE ENDOCARDITIS
	-	NGR; A NOVEL FIBRINOGEN ADHESION MOTIF ENHANCING PLATELET ACTIVATION
	-	A DYNAMIC MODEL OF THE BLOOD-BRAIN BARRIER
Coyle D.A.	-	A COMPARISON OF ANTICOAGULANTS (AC) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS (PROPH) AFTER ORTHOPEDIC SURGERY (OS) USING A CLINICAL COST-EFFECTIVENESS ANALYSIS (CEA) APPROACH
	-	DEFINING BENEFIT-RISK TRADEOFF VALUES FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
	-	SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
Cozzi M.	-	EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
Cozzi M.R.	-	SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
Cozzi E.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Cozzi F.	-	MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
Cozzi M.R.	-	ALTERED BINDING OF PURIFIED TYPE 2M VICENZA VON WILLEBRAND FACTOR TO PLATELET RECEPTOR ALPHAIIBBETA3 AND GPIB-V-IX COMPLEX
Crain E.J.	-	POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Cramer B.G.	-	COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Cramer-Borde E.M.	-	PLATELETS AND VIRUSES
Cramer-Bordé E.	-	BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS
Cramer-Borde E.	-	PLATELET CHEMOTAXIS INDUCED BY THE SDF-1/CXCR4 CHEMOKINE RECEPTOR SYSTEM
Cranenburg E.C.M.	-	Circulating inactive human Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular disease
Cranswick N.	-	UFH PHARMACOLOGY IN CHILDREN
	-	UNFRACTIONATED HEPARIN (UFH) PHARMACOKINETICS IN CHILDREN
Crassard I.	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
Cravatari M.	-	INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Crawley J.T.B.	-	FURTHER CHARACTERISATION OF ADAMTS13 INACTIVATION BY THROMBIN
	-	EVIDENCE FOR TWO FUNCTIONAL CALCIUM-BINDING SITES ON ADAMTS13
	-	LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
	-	THE CENTRAL ROLE OF THROMBIN IN HAEMOSTASIS
	-	SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
	-	VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
	-	NON-CONSERVED/VARIABLE REGIONS IN THE ADAMTS13 METALLOPROTEINASE DOMAIN ARE DETERMINANTS OF SUBSTRATE SPECIFICITY
Creagh M.D.	-	CLINICAL OUTCOMES OF POINT-OF-CARE INR MONITORING FOR ANTICOAGULATION IN PRIMARY CARE PRACTICE
	-	QUALITY OF ANTICOAGULATION MANAGEMENT IN PRIMARY CARE PRACTICE
Creary M.	-	U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION
Cremona S.L.	-	CLINICAL AUDIT OF THROMBOEMBOLISM PROPHYLAXIS 3 YEARS AFTER THE 6TH ACCP REPORT IN A TERTIARY CARE HOSPITAL FROM CRDOBA, ARGENTINA
Crépin M.	-	A NOVEL RECOMBINANT RGD-DISINTEGRIN FROM BOTHROPS ALTERNATUS (DISBA-01) ANTAGONIZES ALPHAIIB-BETA3 AND INHIBITS THROMBOSIS
Crescente M.	-	GALLIC ACID BLUNTS PLATELET INHIBITION BY ASPIRIN AND OTHER POLYPHENOLS: IMPLICATIONS FOR THE ANTITHROMBOTIC PROPERTIES OF ASPIRIN AND DIETARY POLYPHENOLS
	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
	-	RESPONSE VARIABILITY TO ASPIRIN AS ASSESSED BY A PLATELET FUNCTION-ANALYZING DEVICE IN 5,007 SUBJECTS: A SYSTEMATIC REVIEW OF 40 STUDIES
Crikis S.	-	MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
	-	INCREASED CD39 EXPRESSION PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY VIA A REDUCTION IN INFILTRATING CD4+T CELLS: PROTECTION IS AFFORDED BY BOTH EXPRESSIONS ON EITHER TISSUE OR ON CELLULAR BLOOD
Crist R.A.	-	A COMPARISON OF TWO COMMERCIAL ADAMTS-13 ACTIVITY ASSAYS WITH A REFERENCE LABORATORY METHOD
Cristiano M.	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
Critchley D.R.	-	HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
Crittenden J.R.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Croal B.	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
Crosdale D.J.	-	INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
Crowley C.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Crowther M.	-	PLATELET FACTOR V DEFICIENCY IN A PATIENT WITH AN ACQUIRED INHIBITOR OF VA PROCOAGULANT FUNCTION
Crowther M.A.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Crowther M.	-	USE OF A HUMAN-DERIVED D-DIMER PREPARATION IN EXTERNAL QUALITY ASSESSMENT (EQA)
	-	VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS UNDERGOING CHEST SURGERY FOR LUNG OR PLEURAL MALIGNANT DISEASE
	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
	-	D-DIMER REPORTING: WHAT'S THE PROBLEM FOR THE ELECTRONIC HEALTH RECORD? AN ONTARIO PERSPECTIVE
Crowther M.A.	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	LOW-MOLECULAR-WEIGHT HEPARIN IN THE ELDERLY WITH IMPAIRED RENAL FUNCTION
	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Crowther M.	-	LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
Crpp .	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
Cruz M.A.	-	STRUCTURAL AND THERMODYNAMIC EFFECTS OF TYPE 2M AND TYPE 2B VWD MUTATIONS IN THE A1 DOMAIN OF VWF
	-	PURIFIED A2 DOMAIN OF VWF BINDS TO THE ACTIVE CONFORMATION OF VWF AND BLOCKS THE INTERACTION WITH PLATELET GPIB; A NOVEL A2 DOMAIN-DERIVED PEPTIDE INHIBITS VWF-GPIB INTERACTION UNDER HIGH FLOW CONDITIONS
Csapo A.	-	GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS
Csapó A.	-	PRODUCTION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE B SUBUNIT OF FACTOR XIII THAT INHIBIT THE FORMATION OF HETEROTETRAMERIC COMPLEX OF A AND B SUBUNITS
Csapo I.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Cubillo P.	-	ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
	-	PROTHROMBIN AND F1+2 LEVELS ARE SIGNIFICANTLY INCREASED IN SYMPTOMATIC COMPARED WITH ASYMPTOMATIC FAMILY MEMBERS CARRYING THE PROTHROMBIN G20210A MUTATION
Cucchini U.	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Cucherat M.	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
Cuenod C.A.	-	ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
Cuerquis J.	-	THE IMPORTANCE OF THE PROPEPTIDE FOR CARBOXYLATION OF THE VITAMIN K DEPENDENT CLOTTING FACTORS: STUDIES WITH FACTOR IX
Cueto C.	-	EVALUATION OF VARYING CALCIUM CONCENTRATIONS TO IDENTIFY ANTIB2-GLYCOPROTEIN I LUPUS ANTICOAGULANTS WITH A SILICA CLOTTING TIME METHOD FOR LUPUS ANTICOAGULANT TESTING
Cugno M.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Cui Z.	-	COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Cuilleret F.	-	METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
Cuisset T.	-	CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Culakova E.	-	INCREASING RATE OF VENOUS THROMBOEMBOLISM AMONG HOSPITALIZED CANCER PATIENTS
	-	DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR CHEMOTHERAPY-ASSOCIATED THROMBOSIS
Cullinan D.B.	-	INHIBITOR ANTIBODY LE2E9 AGAINST FACTOR VIII C1 DOMAIN INHIBITS PHOSPHOLIPID BINDING AND ALTERS FACTOR XASE ENZYME COMPLEX FORMATION
Cultrera D.	-	THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS
	-	THE HYPERCOAGULABILITY AND VASCULAR ENDOTHELIUM ABNORMAL CYTOKINES' RELEASE MAY INFLUENCE THE PROGRESSION OF THE OSTEOPATHY IN HOMOZYGOUS B-THALASSEMIA PATIENTS
	-	PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN
Cumming A.	-	DETECTION OF PARTIAL F8 GENE DELETIONS IN HAEMOPHILIA A CARRIER DIAGNOSIS
Cummings C.	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
Cummins P.M.	-	A DYNAMIC MODEL OF THE BLOOD-BRAIN BARRIER
	-	THE MECHANO-REGULATION OF LASP-1 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE
	-	MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
Cunanan J.	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
	-	TRYPSIN MEDIATED ACTIVATION OF THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR (CARBOXYPEPTIDASE U)
	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
	-	UPREGULATION OF MICROPARTICLES IN HEPARIN INDUCED THROMBOCYTOPENIA (HIT) AND IT'S MODULATION BY ARGATROBAN
	-	PREGNANCY ASSOCIATED ALTERATIONS OF THE INFLAMMATORY MEDIATORS, TISSUE FACTOR PATHWAY INHIBITOR AND PROTEIN Z
	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
	-	UPREGULATION OF MYELOPEROXIDASE IN END STAGE RENAL DISEASE AND ITS MODULATION BY HEMODIALYSIS
	-	PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
	-	UPREGULATION OF INFLAMMATORY MEDIATORS IN LUNG CANCER AND THEIR MODULATION BY ORAL ANTICOAGULANT THERAPY
	-	UPREGULATION OF SURROGATE MARKERS OF INFLAMMATION AND THROMBOGENESIS IN ESRD PATIENTS, PATHOPHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS
Cung T.	-	DEVELOPMENT AND VALIDATION OF A MULTIPLEXED FLUORESCENT BEAD-BASED IMMUNOASSAY FOR SIMULTANEOUS QUANTIFICATION OF COAGULATION AND FIBRINOLYSIS PARAMETERS IN HUMAN PLASMA
Cunnanan J.	-	SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
Cunningham K.	-	IDENTIFICATION OF POTENT CYCLIC PEPTIDES THAT BIND TO PLATELET GLYCOPROTEIN IB ALPHA AND SELECTIVELY INHIBIT VON WILLEBRAND FACTOR DEPENDENT HIGH-SHEAR PLATELET AGGREGATION
Cunto E.	-	ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS
Cuppini S.	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
Curiale S.	-	ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
Curnow J.L.	-	ANALYSIS OF THE SENSITIVITY OF THE OVERALL HAEMOSTATIC POTENTIAL (OHP) ASSAY TO COAGULATION FACTORS
	-	FIBRIN GENERATION IS NOT SUPPRESSED IN PATIENTS WARFARINISED FOR VENOUS THROMBOEMBOLISM (VTE)
Cursio J.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Curtiss L.K.	-	FLK-1-BASED DNA VACCINATION REDUCES ATHEROSCLEROTIC LESION GROWTH IN HYPERLIPIDEMIC MICE
Curvers J.	-	ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS
	-	FACTOR VA BOUND TO STORAGE INDUCED MICROPARTICLES HAVE REDUCED APC CATALYZED INACTIVATION
	-	DETECTION OF ANTI-HAEMOSTATIC EFFECT OF PLASMA DILUTION VIA THROMBIN GENERATION
Cushman M.	-	THE RISK OF RECURRENT VENOUS DISEASE ASSOCIATED WITH INFLAMMATORY MARKERS AND D-DIMER
	-	EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
	-	COAGULATION FACTORS IX - XIII AND RISK OF FUTURE VENOUS THROMBOSIS: THE LONGITUDINAL INVESTIGATION OF THROMBOEMBOLISM ETIOLOGY (LITE)
Cutler J.A.	-	THE SIGNIFICANCE OF BREAKPOINT DELINEATION IN LARGE DELETIONS IN THE F8 GENE
	-	THE FIRST CAUSATIVE MUTATION OF HAEMOPHILIA A IDENTIFIED IN THE PROMOTER REGION OF THE FACTOR VIII GENE (F8)
Cutler J.	-	UNEXPECTED FINDING OF RAISED UNDERCARBOXYLATED FII (PIVKA-II) IN FVII DEFICIENCY
Cuvelier S.L.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Cuzon G.	-	ORIENTIA TSUTSUGAMUSHI INFECTION (SCRUB TYPHUS) IS ASSOCIATED WITH AN INFRACLINICAL ACTIVATION OF THE COAGULATION SYSTEM BUT NOT WITH AN ACTIVATION OF ENDOTHELIAL CELLS
Cymbalista C.M.	-	HERITABILITY OF MEASURES OF CLOT TURBIDITY AND CLOT LYSIS IN THE LEEDS FAMILY STUDY
Czuriga I.	-	ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
Czyrny Z.	-	EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA

| ISTH 2009